Clinical Trial Update: Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intranasal OPN-375 for chronic rhinosinusitis without nasal polyps has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• OPN-375

Snippet

Sponsor: Optinose US Inc. | Conditions: Chronic Rhinosinusitis | Phase 3 | Status: COMPLETED | Results posted: 2023-12-21